PathXL, a global pioneer in the use of web-based solutions for digital pathology, announced the success of their first user group meeting. Approved by The Royal College of Pathologists for CPD credits, the main focus of the 2 day conference was to get PathXL users interacting, sharing and networking with one another, and the PathXL team.
Held at the Titanic Center Belfast, the event brought together customers from around the globe to discuss their specific application areas, including how PathXL solutions support their goals.
A highlight of the event was Professor Christopher Foster discussing recent publications in leading journals including Nature, Nature Genetics, Science, Elife and European Urology. PathXL products are used by Professor Foster and the team at the International Cancer Genome Consortium (ICGC) to meet all digital pathology needs.
Highly interactive sessions encouraged customers to openly discuss how dedicated application software in digital pathology could support growing needs in the research, clinical and training sectors. These sessions provided customers with the opportunity to contribute ideas to PathXL’s product development roadmap. Very much a two way exchange, all participants were among the first to learn of updates on the latest developments, and on the longer term strategic goals of PathXL.
Considered a “successful and very informative” meeting, Dr. David Snead, Coventry University Hospital, UK, and user of PathXL’s EQA platform stated:
“I was impressed to learn about the different ways the software is being used in other organizations and I’m excited to take this information back and share with my colleagues.”
Speaking post event Des Speed, CEO of PathXL said, “The success of this conference was a result of the open sharing of customer experience and knowledge, we are incredibly grateful to all who contributed. Seeing the amazing value our customers have generated from our solutions gives deep pride and fulfilment to our entire team. All insights gleaned will further enhance our offering to our customers.”
PathXL is a global pioneer in the use of web-based solutions for digital pathology, and provides innovative software for use in drug discovery research, clinical sectors, biomarker analysis and education. Their product for the automated identification and annotation of tumor tissue, TissueMark, was awarded the Frost and Sullivan 2014 European New Product Innovation Award for Automated Image Analysis for Digital Pathology.